Healthcare Committee Discuss Life Science Strategy with Kåre Schultz
Chairman of the government's Life Science Growth Team and Lundbeck CEO Kåre Schultz
Chairman of the Life Science Growth Team Kåre Schultz presenting the 17 recommendations to the Danish government

On April 4, representatives from AmCham's Healthcare Committee gathered for a roundtable discussion with Chairman of the government's Life Science Growth Team and Lundbeck CEO Kåre Schultz. The meeting was hosted by Lundbeck at their headquarter in Valby, Copenhagen.

Kåre Schultz presented the 17 recommendations put forward by the Life Science Growth Team in a report on Friday.  The recommendations are aimed to improve working conditions for life science companies in Denmark in order to generate growth and create jobs.

After Schultz' presentation, committee members engaged in a constructive dialogue on the report and its recommendations and how they - as international companies operating in Denmark - view the outcome of the life science discussions.

About the Committee
AmCham’s Healthcare Committee is a forum for research-based international pharmaceutical and biotech companies, IT companies specializing in healthcare solutions and medical device & instruments companies in Denmark. The committee works with key healthcare stakeholders and decision makers to bring an international perspective to the Danish healthcare debate.

If you are interested in learning more about the committee, please contact AmCham at mail@amcham.dk
or on +45 33 932 932.

07 Bayer10 Weibel01 Manpower DK03 Copenhagen Marriott02 Lockheed Martin05 Crowne Plaza09 Riskpoint06 DXC Technology08 Bristol-Myers Squibb04 MSD11 Roche
AmCham Denmark · Dag Hammarskjölds Allé 13, 3 · 2100 Copenhagen Ø · Denmark · Phone (+45) 33 932 932 · E-mail: mail@amcham.dk · CVR: 24992314
Copyright© 2010 AmCham Denmark · All Rights Reserved